CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer
CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer.
Michaels AD, Newhook TE, Adair SJ, Morioka S, Goudreau BJ, Nagdas S, Mullen MG, Persily JB, Bullock TNJ, Slingluff CL, Jr., Ravichandran KS, Parsons JT, Bauer TW.
Clin Cancer Res. 2017; 24(6):1415-25.
Michaels AD, Newhook TE, Adair SJ, Morioka S, Goudreau BJ, Nagdas S, Mullen MG, Persily JB, Bullock TNJ, Slingluff CL, Jr., Ravichandran KS, Parsons JT, Bauer TW.
Clin Cancer Res. 2017; 24(6):1415-25.
